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abStract
background General practitioners (GPs) are increasingly pressured to prescribe 
cost-effectively, due to rising prescribing expenditure and limited budgets. A com-
puterised prescribing substitution application (ScriptSwitch®) provides ‘pop-ups’ of 
cost-saving drug switches at the point of prescribing. It has been used by some 
United Kingdom local health commissioning organisations as part of a medicines 
management strategy. 
Objective To explore GPs’ views on using this prescribing substitution applica-
tion in their day-to-day clinical practice.
Methods Qualitative study employing face-to-face semi-structured interviews, 
undertaken with a convenience sample of eight GPs across five practices within 
one local health commissioning area in the North of England. Interviews were 
audio-recorded, transcribed verbatim and thematically analysed. 
results Six themes were identified including: (1) GPs’ acceptance, (2) the appli-
cation’s impact, (3) external control, (4) disruption to workflow, (5) GP willingness to 
switch and (6) patient willingness to switch. 
conclusions Clinician, patient and organisational factors were identified which 
were assumed by GPs to affect the engagement with the application. Despite 
 general acceptance of the application to enhance cost-effective prescribing, its 
impact was perceived to be limited within the context of existing cost-effective pre-
scribing initiatives. The application’s perceived lack of ‘learning’—e.g. offering the 
same switch despite the prescriber repeatedly declining this—devalued users’ 
 confidence in it. With patients varying in amenability and acceptance to drug switches, 
GPs appear to experience tension between considering individual patient choice and 
wider  practice population prescribing priorities. Giving GPs more control in adapting 
the application to their own local prescribing priorities may enhance its success. 
Keywords: clinical electronic prescribing, decision support systems, evidence-
based practice, health expenditures, qualitative research
What this paper adds
 • This paper provides insight into end-users’ views of an electronic 
prescribing substitution application used in UK primary care.
 • Similar prescribing applications in primary care need to consider their 
capacity to allow adaptation and ability to personalise interventions in line 
with end-user preferences and practice needs. 
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IntrOductIOn
Rising prescribing expenditure is an international healthcare 
cost burden, despite finite resources and overall restricted 
budgets.1 This inflation relates to contextual factors including: 
increasing drug prices,2 an ageing demographic with preva-
lent chronic disease and pay-for-performance measures 
for primary care clinicians (e.g. the Quality and Outcomes 
Framework in the UK).3–6 Subsequently, average prescription 
items per patient has approximately doubled over a decade,7 
with prescribing expenditure in primary care accounting for 
15% of the entire UK state health (National Health Service) 
expenditure in 2009 and rising.8 General practitioners (GPs) 
initiate 98.5% of primary care prescriptions in approximately 
two thirds of consultations.8 However, GPs do not consis-
tently prescribe cost-effectively in line with best practice.7,9
The development of information technology use and the 
increasing emphasis on evidence-based practice have 
resulted in the implementation of clinical decision support 
tools. Computerised decision support tools at the point of care 
are considered important in promoting best practice.3,9,10,11,12 
Although potentially disruptive, providing evidence-based 
prescribing choices may limit pressure on GPs to find time 
to appraise frequently changing drug information.6,13,14 Such 
interventions look to offer suitable prescribing alternatives 
requiring little ‘mousework’ to initiate or override2,10,15 and pro-
vide GPs support without threat to autonomy.16 The comput-
erised prescribing substitution application ScriptSwitch® (Box 
1, Box 2 and Figure 1) is advocated as a facilitator to cost-
effective prescribing through engaging GPs’ awareness of 
locally promoted, cost-effective drugs7 and their prices. Drug 
cost information has been shown to be a modifiable factor 
in altering prescribing behaviour and welcomed by GPs.1,17,18 
Factors relating to the application itself are important in its 
success for change, but ‘human factors’ also contribute.19 It 
is important to explore GPs’ experiences as application users 
who understand the context and consequences of utilising it 
in day-to-day clinical practice: aspects which can be poorly 
understood by those designing such tools.20 GPs are being 
allocated increasing roles in commissioning and improving 
quality of care. They are expected to provide patient-cen-
tred care alongside a focus on utilising resources to provide 
most benefit to wider patient populations.7 This article aimed 
to explore GPs’ views on using a prescribing substitution 
box 2  characteristics of the prescribing substitution 
application ScriptSwitch®
•  A computerised, active, decision support software, 
which has been deployed in approximately 6,500 
general practices throughout the UK.22 
•  Commissioned as a means to deliver locally preferred 
formulary choices, alongside brief information 
concerning dosage optimisation, safety or efficacy.2,8
•  Provides automatic drug-switch recommendations at 
the point of prescribing and associated cost savings. 
These appear where cheaper drugs (both acute 
and repeat) to ones initially prescribed have been 
pre-programmed via the local health commissioning 
organisation.7,22
•  Drug switches include expensive branded 
drugs to pharmacologically identical generic 
equivalents; expensive to cheaper drugs within 
the same class; switches between generics (e.g. 
preparation); and occasionally generic to cheaper 
brand switches.23
•  Local health commissioning organisations’ Medicines 
Management teams choose and update alerts. 
Data related to switches accepted or declined, and 
the cost savings thereby achieved, are recorded 
and fed back to local health commissioning 
organisations.23
box 1  History of the prescribing substitution application 
ScriptSwitch®21
•  Developed in 2002 by several Warwick University 
students and a pharmacist
•  Venture capital investment helped grow the company
•  A Queens Award for enterprise was awarded in 2009 
•  Sold in 2009 to the American health and wellbeing 
company, United Health Group®, for around £45 million
•  Annual estimated savings at exit were around 
£10 million, with 80% of prescribing substitution 
suggestions leading to some saving
application, to gain some insight into barriers and enablers 
to successfully using such tools to promote cost-effective 
prescribing.
MetHOdS
A literature review looked for studies examining GPs’ views 
on what influences their prescribing behaviour, particularly 
prescribing expenditure. Medline 1948 to present, Embase, 
PsychINFO and Health Management Information Consortium 
were searched during September to October 2011 using 
tailored search strategies, key word and subject heading 
searches. Databases with ‘Autoalert’ function were activated 
to bring relevant, new publications to the researcher’s atten-
tion. Relevant grey literature including Government reports 
were also reviewed, alongside some relevant primary care 
prescribing and informatics textbooks. The literature review 
did not identify any literature on GPs’ views on using this 
particular prescribing substitution application, but did identify 
papers and grey literature on the use of prescribing decision 
support systems.
Qualitative methodology
A qualitative methodology was chosen to facilitate explora-
tion and understanding of GP participants’ attitudes and 
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Figure 1 Flow diagram demonstrating the functioning of the prescribing substitution application ScriptSwitch®
experiences with the application.24–26 Use of semi-structured 
interviews and open questions provided more in-depth 
responses and insight24,26,27 for thematic analysis.
Sampling
Medicines management data from one local health com-
missioning organisation in the North of England identified 
practices who had recently used or were currently using the 
prescribing substitution application. A convenient sample of 
fourteen practices within the above locality was identified.
recruitment
Individual GPs’ names were obtained from the fourteen prac-
tices’ websites. The only exclusion criterion was GPs within 
these practices who did not activate the prescribing substitu-
tion application. Ninety eight GPs received hand-delivered, 
printed participation invitations and information sheets. A sec-
ond batch was posted to non-responders after two weeks. 
Willing GPs emailed the researcher to organise convenient 
interview times and settings. 
data collection
Semi-structured interviews used a topic guide (see 
Appendix 1) to focus discussion, facilitate reflection, and 
explore experiences and attitudes.27 The topic guide was 
piloted with one GP. The data was retained as the topic 
guide remained unchanged. GPs had opportunity to ask 
questions before signing consent forms. Interviews took 
place at the GPs’ practices.
data analysis
All recorded interviews were transcribed verbatim, ano-
nymised and analysed as soon as practicable after 
interviews. Inductive thematic analysis was considered 
appropriate to identify themes as ‘repeated patterns of 
meaning’.29 The researcher (CH) became familiarised with 
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data through extensive re-reading alongside development 
of descriptive codes within most lines of text.30 Coded data 
extracts and participant number were electronically cut and 
pasted into separate word documents to allow grouping of 
linked and contradictory codes across all transcripts. Files 
were labelled with provisional interpretive code names and 
printed.30 Occasionally descriptive codes were hand-cut 
and reorganised under different interpretive codes, which 
were grouped under overriding key themes. Themes were 
categorisable as being related to either the context of pre-
scribing; the application, or the doctor and their patients 
involved. Regular referral to original transcripts ensured 
data interpretation in context. Transcripts, codes and pro-
posed themes were exchanged with a fellow researcher to 
ensure agreement, enhance rigour and minimise researcher 
bias or misinterpretation.31
reSultS
A total of eight GPs (Table 1) across five practices partici-
pated in interviews lasting up to half an hour.
table 1 demographics of participants
GP Gender Practice 
population 
(approx)
Years 
as GP
Total  
GPs in 
practice
Perception of 
prescribing 
expenditure
Dr 1 Male 12000 10 11 Good side of 
average
Dr 2+ Female 11000 30 11 Just under 
average
Dr 3+ Male 11000 9 11 On average
Dr 4 Male  6000 10  8 Rather over the 
average
Dr 5* Female 12000 9 12 Moderate
Dr 6^ Female  7000 10  6 Generally on 
budget
Dr 7^ Male  7000 8  6 Relatively low
Dr 8* Female 12000 11 12 About average
+ From same practice
* From same practice
^ From same practice
Six themes were identified within the data:
1. GPs’ acceptance of the prescribing substitution 
application,
2. the application’s impact,
3. external control,
4. effect on workflow,
5. GPs’ willingness to switch and
6. patients’ willingness to switch.
The themes will be discussed alongside relevant quotes, in 
the following three sections. 
context of cost-effective prescribing agenda
Cost-effective prescribing had been on GPs’ and practices’ 
agendas for some time before prescribing substitution appli-
cations were introduced. All GPs welcomed this particular 
application’s implementation in an attempt to limit unneces-
sary prescribing expenditure, although some were sceptical 
of its potential impact.
I think for a lot of practices which hadn’t been so vigilant 
about their prescribing costs it was a really good idea, a 
good way to kind of, you know, alert people to potential 
cost savings. (Dr 2, practice 2)
I was a little bit sceptical that it would make a huge 
amount of difference to us, because, you know our pre-
scribing was already, well we thought was already of a 
good standard. (Dr 8, practice 4)
There were varying experiences and perceptions of this pre-
scribing substitution application’s impact on altering GPs’ 
prescribing behaviour and expenditure amongst initiatives 
already in place. Several discussed the application more in 
terms of a reinforcer or reminder, rather than promoting new 
drug cost knowledge. 
The big drugs, the cost saving drugs, we were already 
driving towards them, we were already very aware of 
them … we didn’t need a computer system to tell us that. 
(Dr 7, practice 5) 
We’ve been working at this for a long time. A lot of 
those messages weren’t, weren’t new to us. (Dr 3, 
 practice 2)
A range of cost-effective prescribing initiatives and 
improvements were mentioned as limiting the application’s 
impact, including practice formularies, generic prescribing, 
medicines management support and financial incentives. 
However, most still discussed how this application would 
be helpful to practices outside of the area with less cost-
effective prescribing support in place. This notion was sup-
ported by the only GP (Dr 4) who admitted to working in 
a practice with high prescribing expenditure and limited 
practice formulary felt they were being alerted to frequent 
cost-saving switches.
I know there are some areas of the city where, the sort 
of, the history of medicines management and the prac-
tices haven’t been quite as good, that ScriptSwitch® was 
much better at making changes because there was still 
lots of prescribing behaviour that could be altered. (Dr 3, 
practice 2)
I mean the obviously one was dispersible aspirin I 
think is cheaper than normal aspirin - which I hadn’t 
realised. And yeah it’s only a few pence but you pre-
scribe so much of the stuff that it makes sense. (Dr 4, 
practice 3)
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The variation in perceived value and impact of the application 
in making change inevitably influenced attitudes towards its 
long-term use. 
The value of ScriptSwitch® was mostly in those first 3 to 
6 months when it was about changing people’s practice 
and getting people into a habit of doing something … 
once that had become habitual and had become assimi-
lated, then the value of it I think became less … the focus 
had been on to cost. (Dr 1, practice 1) 
I think it was sad it was, it ended in North [city] because 
I felt it was, was a real … helpful addition to the, the tool-
box if you like. (Dr 4, practice 3)
application-related issues
Two themes related to how this application functioned. A cou-
ple of GPs discussed how its pop-up acceptance/decline data 
and savings within practices were collated by the local health 
commissioning organisation and reports disseminated back 
to the collective of practices. There were mixed views about 
the appropriateness of this. 
I’m not sure that guilt is a good driver sometimes to 
change […] The thing I didn’t like about it was the 
reports that came around every month, telling you how 
you, or telling me, how badly I’d done compared to 
everybody else […] it was a bit of a sting sometimes 
when you found you hadn’t done very well that month. 
(Dr 4, practice 3)
It’s difficult to know how ones’ prescribing does com-
pare with other practices … we get some feedback, but 
it’s very generalised. So the concept that all, a large 
number of practices in the area might also be going 
through the same exercise was good in the sense that 
it might be driving standard up across the district. (Dr 8, 
practice 4)
Although GPs could feedback to the their local Medicines 
Management team, many appeared frustrated by their 
own lack of control over what was communicated and 
targeted within the application’s pop-ups being sent to all 
practices.
I personally didn’t like about it, was the fact that it was 
centrally controlled and it wasn’t something that we had 
any influence over. So there were lots of sort of issues 
that particularly maybe weren’t an issue for this particu-
lar practice, and maybe issues that there were. But we 
you know we couldn’t influence on ScriptSwitch® what it 
was telling us to do. (Dr 1, practice 1)
Perhaps almost slightly bombarded a little bit too 
much with almost sort of some very basic things. (Dr 6, 
practice 5)
Slow updating of the application’s pop-ups by the local 
health commissioning organisation was mentioned as 
causing pop-up repetition, making some suggestions out 
of sync with recent clinical guidelines or associated with 
decreasing cost savings.
Issues which were initially sensible and relevant either 
became less relevant or became obsolete because of 
changes in pricing by the pharmaceutical companies […] 
Switches were being suggested which okay initially were 
clinically thought to be fine, but later maybe because of 
changes in clinical guidance actually became inappropri-
ate. (Dr 1, practice 1)
The kind of trickle of information that came after the ini-
tial surge was perhaps not enough to keep us enthused 
with it. (Dr 8, practice 4)
However, there were variable perspectives on the extent to 
which the application impacted upon workflow. Several GPs 
recognised value in repetition, but appeared to indicate in the 
long term this may have became increasingly intrusive and 
devalued the software.
We know you have to keep telling doctors again and 
again and again if you’re going to make change, but 
actually if you’re being told the hundredth time the 
same message about using this drug instead of this 
drug or using trimethoprim for three days instead of 
five, you’ve got the message. And you sort of almost 
want to switch that message off, and put a new one on. 
(Dr 3, practice 2)
Most of the time it was just reminding us of things that 
we ought to be doing anyway, so that was good up until 
it became ‘yes but we know that, thank you’ (laughs). 
(Dr 1, practice 1)
There’s a limit to the tolerance to which you’ll accept 
those or look at those prompts over and over again. 
(Dr 8, practice 4)
There were variable attitudes towards the value of a potential 
ability to respond to the application’s alerts. Some mentioned 
potential benefit in blocking repetitive pop-ups, whilst others 
perceived this would cost time and effort. 
I like to prescribe this particular steroid cream a lot in my 
dermatology work. If I’d had the opportunity to maybe 
say, I don’t want to switch this particular brand, if I opt 
to prescribe this item, please don’t ask me if I want to 
switch. (Dr 2, practice 2)
You’d have to customise it to some degree, it’s not a 
one package suits all scenario unfortunately […] then 
what you’re talking about is time feeding back into 
the system, we’ve got 10 minute consultations, we’re 
already pushed for time, it’s very difficult to do that in 
clinical practice […] you’re taking away from that patient-
centred focus in that consultation. (Dr 7, practice 5)
The majority of GPs mentioned ease in overriding pop-
ups prevented too much intrusion, with one GP implying 
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desensitisation to pop-ups due to clinical systems wide-
spread use in primary care.
I didn’t find it particularly intrusive because it’s a sim-
ple ‘do you want to make the switch? Do you not want 
to make the switch?’ box. So it’s very easy to hit no. 
(Dr 3, practice 2)
It had to use the same irritating pop-ups that we’re 
used to with SystmOne®. So, I actually, I didn’t find it that 
bad. (Dr 4, practice 3)
There were varying preferences for how pop-ups should 
ap pear on screen. A few GPs perceived the application soft-
ware as being an additional bolt-on to the consulting system 
and prescribing process, suggesting there could be more 
integration. 
Rather in the middle of a screen, on the edge of the screen, 
so that it’s there in the background rather than in your face, 
so that you’ve got it to refer to if you want to but you don’t 
feel like it smacks you in the eye. (Dr 8, practice 4)
I probably wouldn’t design ScriptSwitch® to be used 
by GPs because it’s a very in your face system. (Dr 7, 
practice 5)
The computer was fine, because it popped up, it was 
visible […] it was very clear and you could easily choose 
to cancel it or go with its suggestions. So, that worked 
quite well. (Dr 5, practice 4)
Because it is a system which is external to what we’re 
using consulting wise, then, it does mean that it is an 
extra process to go through - it can’t seamlessly inte-
grate […] anything that adds the number of clicks to what 
you have to do per consultation is a potential annoyance 
… because there’s always a lot of mouse work to do. 
(Dr 1, practice 1)
In consultation decision making
Final themes related to the fact that both doctors and patients 
have individual views and attitudes towards cost when pre-
scribing. Most GPs discussed cost when prescribing as 
important, however its prioritisation varied.
There are some people [GPs] who are either not inter-
ested or actually see it [cost] as something that gets in 
their way, or even find, sometimes like to be … delib-
erately ignore so to speak (laughs). Generally speak-
ing most people are sort of switched on these days and 
know they should be getting value for money from what 
they prescribe. (Dr 1, practice 1) 
[Cost when prescribing is] not as important as clinical 
effectiveness I suppose […] I’d have said to the patient 
something was expensive or I was using something 
because of their desire to use something. (Dr 6, practice 5)
I think economy has a very big part to play, so it is 
important in its realm, but I wouldn’t consider it as the 
most important thing to think about in consultations […] 
Patient choice is the obvious [conflicting] one […] I sup-
pose because we are very patient-centred, we tend to 
put economic I suppose wrongly sort of somewhere 
down the list third or fourth really. (Dr 4, practice 3)
Several GPs felt that the application’s suggestions based on 
cost-saving were at times inappropriate, being either clini-
cally or patient irrelevant.
If you’d have made every single switch that ScriptSwitch® 
suggested, you would have saved a whole lot of money, 
but, clinically speaking, many of them weren’t appro-
priate. Now whether that’s because the system is just 
comparing spreadsheet on spreadsheet, so there’s noth-
ing sort of a clinical basis to that, because of cost basis. 
Or whether it’s because as you sit here and you’re inter-
viewing a patient, you’re looking at the records, you know 
a lot more about that patient, therefore, you know, you’re 
more likely to refuse a change. (Dr 7, practice 5)
Several GPs described the application’s substitution sugges-
tions as helpful and implementable when clinically equivalent 
suggestions did not require switching to completely different 
drugs. 
It occasionally tried to, claim equivalences between 
drugs or doses which weren’t actually equivalent. So it 
would sometimes ask you to substitute someone who 
was on Co-Codamol 30/ straight 500mg to 8/500mg or 
something of that nature, which is clearly nonsensical 
[…] I definitely know there was one particular thing that 
we used to prescribe a lot of where there was another 
you know perfectly acceptable clinical equivalent which 
was, was vastly cheaper. (Dr 1, practice 1)
You think ‘oh yeah, it’s the same medication, just a 
little bit more that they have to take’ and actually cost 
saving was huge. So in that instance, it made sense. It 
was one of those things where it was directly compara-
ble, it was interchangeable, it was the same medication, 
it wasn’t a switch from one medication to another […] 
very little impact on the patient, no impact on the health 
of the patient yet you could make quite a big cost saving 
in those circumstances. (Dr 7, practice 5)
Furthermore, the potential cost saving associated with a 
switch and judgement on its worthiness was influential on 
whether the application’s substitution suggestions were 
implemented. 
‘Change them to this and you’ll save a penny’ … you just 
have one patient that you know has been on it 18 years 
now, and I’m not going to change something for the sake 
of a penny. (Dr 7, practice 5) 
But it was probably saving pennies, and it wasn’t … no 
real value to the patient. (Dr 5, practice 4)
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The product that it was offering you instead, would be 
so close to what you were already using that it didn’t 
seem worth making the switch […] Close in price yeah. 
(Dr 8, practice 4)
Patient preference for particular drugs was influential if 
switches were implemented. Some GPs indicated a sense 
of obligation to prescribe some patients’ preferences, per-
haps indicative of practice ethos or a particularly demanding 
patient population.
A patient might be very keen to try a certain product and 
it might not be the one that you’d prescribe or you might 
not feel that it was so necessary, but you end up pre-
scribing for them. I think there’s lots of times where you 
do recognise that the evidence base for certain medica-
tions just isn’t strong.… But you know patients for what-
ever reason feel that medication does benefit them in 
some way, and it might be a placebo or habitual thing. 
(Dr 8, practice 4) 
Sometimes we’re up against their wanting the non 
generic - that’s very rarely to be honest - but sometimes 
they swear by a particular brand and we are occasionally 
pushed into prescribing that. (Dr 5, practice 4)
One GP suggested that sometimes judgements are made 
about whether to even broach a suggested drug switch 
depending on their perception of the patient’s amenability.
Sometimes you’re busy or the patient, you know to kind 
of go through it with a patient and say ‘well there’s not 
really very much evidence for this’ or ‘this might be a  better 
option’ or ‘have you ever thought about this approach?’ … 
 sometimes within the confines of the consultation you don’t 
feel like you want to go down that road (laughs) … some-
times you can. (Dr 8, practice 4)
GPs mentioned varying confidence levels in discussing drug 
costs and impact on wider health services with patients. 
Generally it appeared GPs felt patients were not opposed to 
cheaper drug switches. 
If a patient realises that the cost in one area goes down 
then it means there’s money elsewhere for services to 
improve […] Some inhalers are £2, others are £30. And 
just actually seeing that, and we convey that information 
to the patient, I think often does make a difference. (Dr 7, 
practice 5) 
If actually it is cost that would stop us prescribing 
something we’d be happy to say to them [patients], that 
if it is effective we’ll use it but if it’s not then there’s no 
reason for us to use something that … when there may 
be cheaper alternative. (Dr 6, practice 5)
It would depend on my relationship with the patient, 
sometimes you can say to the patient ‘oh my goodness, 
I’ve just realised there’s one that’s loads cheaper, let’s 
give you that’ and they’d be quite happy to go with that. 
Some patients wouldn’t be … so amenable to that […] 
There’s perhaps an expectation that the more something 
costs, the better quality it is, and you don’t want to be giv-
ing the patients a budget version when there’s a deluxe 
version available. (Dr 8, practice 4)
PrIncIPal FIndInGS
The findings demonstrate GPs were generally accepting of 
the prescribing substitution application’s attempts to reduce 
prescribing costs, but the majority were underwhelmed by its 
impact amongst other cost-effective prescribing initiatives. 
A major barrier appeared to be lack of GP control over the 
application. This was in terms of alert content and the inabil-
ity to filter pop-ups, as the application could not integrate 
 clinical patient information already in the electronic record, 
thus making irrelevant suggestions. Drug-switch recommen-
dations were considered most helpful when clinically equiv-
alent, minimising personal and health impacts on patients. 
Furthermore, the fact that prescribing is for an individual 
patient, sometimes barriers appear to exist in patients’ per-
ceptions and preferences. 
Implications of findings
The findings demonstrate that more control, adaptability and 
flexibility in such prescribing substitution applications could 
facilitate engagement of GPs more successfully. If there 
were options for customisation at practice level for indi-
vidual GPs, this may enhance its acceptance despite being 
implemented externally. Findings indicate that GPs may 
prefer to be able to select a simpler system, for instance 
to permit only same drug switches as opposed to different 
drug suggestions. 
Findings also demonstrate challenges faced by GPs in 
prescribing cost discussions in consultations with patients. 
Results provide further insight into wider tensions associated 
with balancing patient-centred GP roles with duties to pre-
scribe cost-effectively to ensure fair distribution of resources 
for the wider patient population. Although the GPs mentioned 
budget awareness, this consideration will become increas-
ingly more important for changing primary care landscapes, 
for example, the recent formation of clinical commissioning 
groups in the UK. However, prescribing expenditure contain-
ment remains an international issue given the global eco-
nomic downturn, an ageing demographic and the associated 
increased healthcare costs. 
cOMParISOn WItH exIStInG lIterature
Prescribing decision support software often have variable 
effects,2,32 and although cost-saving drug alternatives at 
point-of-care have been considered useful,10 these are often 
used on ‘trial and error’ basis,9 with availability not necessar-
ily corresponding with change.19
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Repetition and irrelevant patient or clinical suggestions 
promote resistance,33–35 particularly when GPs must respond 
before continuing the process.36 Alerts deemed controversial 
are regularly overridden2 and there is preference for equiva-
lent switches to limit disruption to patient’s care.15 However, 
GP commitment3 to and preference of drugs can also cause 
overriding of suggestions12 against the evidence base,15 
with prioritisation of safety; clinical effectiveness and patient 
preference over cost.18 GPs report a desire to customise 
alerts14,36 at a local level to meet their needs20 and reduce 
concern for unknowingly accepting outdated or unsuitable 
suggestions.37 This coupled with flexibility to alter interface 
display after real-life use38 could help maintain GPs’ interest 
and acceptance37 amongst various other prescribing initia-
tives.14 Furthermore, strong communication links with medi-
cines management teams help to modify or remove unhelpful 
alerts2 and minimise the sense of surveillance or singling out 
of less cost-effective practices.15 Perhaps in relation to this, 
a recent review of features of effective computerised clinical 
decision support systems suggests that systems requiring 
practitioners to supply a reason if overriding advice are more 
likely to be successful.39 
However, pop-ups are considered unacceptable where they 
are perceived to negatively affect workflow, doctor-patient 
communication and relationships.19,33,38,40 As results indicate, 
simple cost-cutting substitutions such as generic prescribing 
are largely in place,23 and further cost-cutting is increasingly 
difficult despite GPs welcoming cost-information.1,17,18
Practitioners must make decisions on whether potentially 
small therapeutic benefits for individual patients are worthy of 
large costs to larger patient groups,14,18 creating tensions and 
ethical dilemmas.17,41,42 A utilitarian ethical perspective would 
permit cost-reduction to maximise limited resources to ben-
efit the most42; however, GPs face pressure from individual 
patient demands and choices.41 The ‘double-agent dilemma’ 
of GPs as doctors but also commissioners may jeopardise 
patients’ trust if GPs are seen to be making decisions with an 
economic mindset over acting as an advocate for individual 
patients.43 Thus patient understanding may be a major con-
tinuing barrier to drug switching. A recent review into clinical 
decision support success suggests a system, which provides 
simultaneous advice to both clinician and patient may be 
more empowering and effective.39 
Unintended consequences of prescribing substitution appli-
cations, in terms of GPs’ behaviour and putative savings, also 
need to be considered. For example, in relation to consul-
tation workflow and generic prescribing, if GPs were to use 
applications as a ‘short cut’ by entering memorable brand 
names as a quick way of accessing the names of generic 
drugs which they had always intended to prescribe, then the 
system-logged ‘savings’ would in fact overestimate actual pre-
scribing savings. Indeed, any business model for prescribing 
substitution applications which charges commissioners on 
the basis of a percentage of the subsequent putative savings 
might thereby generate extra costs for commissioners as a 
result of such unintended consequences. 
limitations of method
The study’s small sample, dictated by GPs’ willingness to 
participate and short timescale and scope of project, limits 
any claims for generalisability or transferability of the study 
findings. GPs were from practices in a small geographical 
area, therefore had similar medicine management input from 
the same health commissioning organisation. The smaller 
sample however provided complex, rich data saturated with 
similar themes.25 
Convenience sampling in an area where the prescribing 
substitution application use had ended may have introduced 
potential memory bias, with selective experiences or behav-
iours recalled.25 Furthermore, the low response rate means 
that those who were keen to participate may hold particu-
larly strong views with regard to the application or prescrib-
ing issues, and may therefore not be representative of other 
GPs. Triangulation of data using alternative methods would 
have improved study validity and rigour, but was limited by 
project resources. 
calls for further research
Extending this research to include participants in other areas 
with different levels of cost-effective prescribing and initia-
tives may be of use.
cOncluSIOn
Prescribing substitution applications may benefit from intro-
ducing more features that allow adaptability to personalise 
interventions in line with GP and practice needs. The poten-
tial benefits of the application appear to be recognised by 
the GPs interviewed, but there was a sense that updates 
which allowed the system to ‘learn’ from clinicians’ prior 
choices may facilitate its success and long-term accep-
tance. Being responsive to the end-users’ perspective may 
be of particular importance in light of the increasing GP 
commissioning roles and enhanced pressures to contain 
prescribing expenditure. 
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aPPendIx
topic Guide: General practitioners’ experiences of and views towards using ScriptSwitch: 
Qualitative study of GPs who trialled ScriptSwitch
Ask participant to say (brief information):
1. Years working as a general practitioner (GP), number of GPs at practice, small or large expenditure 
practice
experience of ScriptSwitch (any points in italics are just prompts for the student researcher if initial question 
does not provoke response, therefore will not necessarily be asked)
1. How important is having cost information to you when prescribing?
2. How was the experience of using ScriptSwitch early on?
1) Was it integrated smoothly into your practice?
2) Was it easy to use?
3) How often did use its recommendations?
3. What were your attitudes towards ScriptSwitch early on?
1) How did you feel towards the introduction of ScriptSwitch?
2) About electronic prescribing support?
3) About electronic prescribing support which emphasises cost?
4. did your experiences or attitudes towards ScriptSwitch change over time at all?
1) If yes, Why?
5. can you give me any examples of how ScriptSwitch helped you when prescribing in the 
consultation?
6. can you give me any examples of how ScriptSwitch did not help in some situations?
Why is your perspective on why scriptswitch use was ended?
Do you have any ideas which would have improved its influence on prescribing decisions?
7. What support or ideas do you feel will help to control prescribing expenditure?
8. closing remarks: anything else you wish to say? thank you.
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